Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol.

MLA

Crowther, Caroline A., et al. “Australasian Randomised Trial to Evaluate the Role of Maternal Intramuscular Dexamethasone versus Betamethasone Prior to Preterm Birth to Increase Survival Free of Childhood Neurosensory Disability (A*STEROID): Study Protocol.” BMC Pregnancy & Childbirth, vol. 13, no. 1, June 2013, pp. 1–7. EBSCOhost, https://doi.org/10.1186/1471-2393-13-104.

APA

Crowther, C. A., Harding, J. E., Middleton, P. F., Andersen, C. C., Ashwood, P., & Robinson, J. S. (2013). Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol. BMC Pregnancy & Childbirth, 13(1), 1–7. https://doi.org/10.1186/1471-2393-13-104

Chicago

Crowther, Caroline A., Jane E. Harding, Philippa F. Middleton, Chad C. Andersen, Pat Ashwood, and Jeffrey S. Robinson. 2013. “Australasian Randomised Trial to Evaluate the Role of Maternal Intramuscular Dexamethasone versus Betamethasone Prior to Preterm Birth to Increase Survival Free of Childhood Neurosensory Disability (A*STEROID): Study Protocol.” BMC Pregnancy & Childbirth 13 (1): 1–7. doi:10.1186/1471-2393-13-104.